ARTICLE
23 October 2026

Healthcare And Related Sectors Invited To Comment On Proposed Hazardous Substances Fees

KI
KISCH IP

Contributor

With an entrenched history in Africa, we have, for the last 145 years, assisted clients from individuals to multi-national corporations in all sectors, in safeguarding their intellectual property rights. While acknowledging our established past, we continue to offer relevant and innovative IP services across Africa, an ever-changing and developing landscape that requires specialist knowledge to succeed.
The South African Department of Health has published proposed Regulations regarding fees payable under the Hazardous Substances Act, 15 of 1973, for public comment. The proposed Regulations introduce a revised fee structure applicable to Group III and Group IV hazardous substances, covering a range of regulatory activities, including applications for licences and authorisations, amendments, renewals, imports and exports, transfers and inspections. The proposed Regulations also prescribe penalties for specified instances of non-compliance.
South Africa Food, Drugs, Healthcare, Life Sciences

The South African Department of Health has published proposed Regulations regarding fees payable under the Hazardous Substances Act, 15 of 1973, for public comment.

The proposed Regulations introduce a revised fee structure applicable to Group III and Group IV hazardous substances, covering a range of regulatory activities, including applications for licences and authorisations, amendments, renewals, imports and exports, transfers and inspections. The proposed Regulations also prescribe penalties for specified instances of non-compliance.

The proposed framework may have financial and operational implications for stakeholders operating in affected sectors, including healthcare facilities, manufacturers and importers of regulated medical and electronic products, laboratories, research institutions, radiology and imaging facilities, and businesses using regulated radiation equipment or radioactive sources.

Affected stakeholders should consider reviewing the proposed fee structure against their existing and anticipated regulatory activities to assess the potential impact on compliance requirements and associated regulatory costs.

Interested parties are invited to submit substantiated comments or representations to the Director-General of Health within three months of publication of the notice on 7 August 2026.

To view the proposed Regulations in full, please click HERE.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More